Partner Headlines - BIIB

  1. Biogen: 'A Nice Little Trade' Or Heading To New Lows?

    Benzinga
  2. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    Benzinga
  3. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga
  4. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders ...

    GuruFocus
  5. Using ETFs To Run Your Own Hedge Fund

    Benzinga
  6. Morning Market Gainers

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. AGTC Release Confirms Strategic Collaboration With Biogen Effective ...

    Benzinga
  9. The Best Companies of the Pharmaceuticals Industry - August 2 ...

    GuruFocus
  10. Benzinga's Top Initiations

    Benzinga
  11. IBD's Big Cap 20 Stocks Offer Refuge In Choppy Market

    IBD
  12. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus
  13. These Two Biotechs Boast Big EPS Growth Rates

    IBD
  14. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD
  15. Regeneron Tops 3 Med Stocks Moving Big On Earnings

    IBD
  16. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD
  17. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  18. Which Big-Cap Stocks Are Defying Market Pressure?

    IBD
  19. Caution Continues In Options Market This Week

    Benzinga
  20. A Big Day For Biotech And It's Not Going So Well

    Benzinga
  21. Benzinga's Volume Movers

    Benzinga
  22. A Look Ahead: Biotech And Energy ETFs To Watch This Week

    Benzinga
  23. Benzinga's Top Downgrades

    Benzinga
  24. Biogen Enters Collaboration with the Parkinson's Institute and ...

    Benzinga
  25. Biotech Stocks Falling Broadly, Here's Why And How Much

    Benzinga
  26. Biogen Tumbles On Outlook

    IBD
  27. Biotech IPO Boom Gaining Thrust With NantKwest Debut

    IBD
  28. Biogen Hacks Guidance, Raising Questions About Future

    IBD
  29. Stocks Fall For Fourth Day On Global Growth Worries

    IBD
  30. Major Indexes Extend Losses; Sucampo Bucks Weakness

    IBD
  31. Mid-Day Market Update: U.S. Stocks Slide; Marketo Shares Surge ...

    Benzinga
  32. Market Update: Friday's Mid-Day Market Movers: Amazon Shocks ...

    Benzinga
  33. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD
  34. Stocks Lower Near Midday; LogMeIn Breaks Out

    IBD
  35. Biogen Plunges On Slashed Guidance; AbbVie Q2 Mixed

    IBD
  36. Mid-Morning Market Update: Markets Slightly Higher; Amazon Earnings ...

    Benzinga
  37. Stocks Open Mixed And Wild; Maxim, Visa, Amazon Spike

    IBD
  38. Morning Market Losers

    Benzinga
  39. Benzinga's Top #PreMarket Losers

    Benzinga
  40. US Stock Futures Edge Higher; Amazon Profit Beats Views

    Benzinga
  41. Biogen Posts Higher Q2 Earnings, But Sales Miss Views

    Benzinga
  42. Earnings Scheduled For July 24, 2015

    Benzinga
  43. 10 Must Watch Stocks for Today

    Benzinga
  44. Stocks Extend Losses; Amazon, Visa Headline After-Hours Action

    IBD
  45. Alzheimer's Data Diverge

    IBD
  46. Illumina Breaches Key Level On Q2 Sales Miss

    IBD
  47. Biogen, Lilly Alzheimer's Data Spark Street Debate

    IBD
  48. Are We Any Closer to Finding a Drug to Battle Alzheimer's?

    FoxBusiness
  49. Earnings Loom For Handful Of Top Big Cap 20 Stocks

    IBD
  50. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD
  51. Why Big Biotech Could Have Another Leg Up

    Benzinga
  52. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  53. Benzinga's Top Upgrades

    Benzinga
  54. Don't Count Out Top Biotechs — They Still Got Game

    IBD
  55. Stocks Up For Second Day; Netflix, Allegiant Jump

    IBD
  56. Biogen Loses R&D Head As Alzheimer's Drug Data Loom

    IBD
  57. Stocks Hold Gains; Alaska Air Flies Near Buy Point

    IBD
  58. Douglas Williams to Leave Biogen for Biotechnology Start-Up

    Benzinga
  59. Stocks: Strong Gains, Light Trade; Liberty Global, NXP Lead Nasdaq ...

    IBD
  60. Morning Market Losers

    Benzinga
  61. Benzinga's Volume Movers

    Benzinga
  62. Biogen, AGTC find genetic link

    IBD
  63. Mid-Afternoon Market Update: International Speedway Slips On ...

    Benzinga
  64. Mid-Day Market Update: US Stocks Down; Xoom Shares Jump On Acquisition ...

    Benzinga
  65. Thursday's Mid-Day Movers: Real Good Solar, Xoom, ConforMIS, ...

    Benzinga
  66. Biogen, AGTC Link Up To Develop Gene Therapy

    IBD
  67. Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire ...

    Benzinga
  68. Benzinga's Volume Movers

    Benzinga
  69. Morning Market Gainers

    Benzinga
  70. Benzinga's Top #PreMarket Gainers

    Benzinga
  71. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD
  72. Roche 'High Efficacy' MS Drug Succeeds In Trials

    IBD
  73. Perrigo Going Up With Or Without Mylan, Says BMO

    IBD
  74. Biogen Phase 3 Study Of Aducanumab

    Benzinga
  75. Health Care Stocks Power S&P 500 To Q1 Earnings Beat

    IBD
  76. Stocks Stay In The Red, But IPOs FitBit, Fogo Score Big Gains

    IBD
  77. Fitbit Keeps Up Pace As Stocks Remain Near Session Highs

    IBD
  78. Big Biotech Stocks See Declining Short Interest

    Benzinga
  79. Isis rises on drug's results

    IBD
  80. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD
  81. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD
  82. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD
  83. Investment Strategies for the Bullish Biotech Sector

    GuruFocus
  84. Apple, SunEdison and Biogen: Hellman, Jordan Management's Top ...

    GuruFocus
  85. PRIMECAP Sells Portions of Its Top Two Stakes

    GuruFocus
  86. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD
  87. 5 NASDAQ Healthcare Stocks With The Highest EPS

    Benzinga
  88. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD
  89. China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back

    IBD
  90. 3 Biotech Stocks See Growing Short Interest

    Benzinga
  91. Q1 Earnings Drive Industry Group Winners And Losers

    IBD
  92. SolarEdge Shares, Up 15%, Lead Techs' Late Rise

    IBD
  93. BIOGEN

    IBD
  94. Frothy China Or No, World Mutual Funds Topped In April

    IBD
  95. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD
  96. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus
  97. Growth Names Pressured As IBD 50 Slumps 4% For Week

    IBD
  98. Vanguard Healthcare Fund Adds Four New Positions

    GuruFocus
  99. Top-Rated Biotech Unravels Base-Building Effort

    IBD
  100. Biogen or Bluebird: Which Will Lead in SCD?

    GuruFocus
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!